Drug Shortage Report for VYVANSE
| Report ID | 220802 |
| Drug Identification Number | 02439603 |
| Brand name | VYVANSE |
| Common or Proper name | Lisdexamfetamine dimesylate capsules |
| Company Name | TAKEDA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LISDEXAMFETAMINE DIMESYLATE |
| Strength(s) | 10MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | Bottles of 100's |
| ATC code | N06BA |
| ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2024-02-27 |
| Actual start date | 2024-02-27 |
| Estimated end date | 2024-03-31 |
| Actual end date | 2024-03-15 |
| Shortage status | Resolved |
| Updated date | 2024-03-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-03-18 | French | Compare |
| v4 | 2024-03-18 | English | Compare |
| v3 | 2024-02-28 | English | Compare |
| v2 | 2024-02-27 | French | Compare |
| v1 | 2024-02-27 | English | Compare |
Showing 1 to 5 of 5